L O Frøholm - Concepedia

Author

L O Frøholm

Also Known As

L O Frøholm, L Oddvar Frøholm, L. Frøholm, L. O. FROHOLM, L. O. FRØHOLM, L. O. Froholm, L. O. FrØHolm, L. O. FrØholm, L. O. Frøholm, L. O. Fr�holm

Publications

Citations

H-Index

Concepts

All Affiliations

University of Oslo Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy Haukeland University Hospital National Institute of Occupational Health University of Bergen

About

L O Frøholm is an author at University of Oslo specializing in medicine, infection control, and bacterial meningitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	46	3.4K
2	Health Sciences	12	13	840
3	Natural Sciences	6	6	118
4	Engineering	2	2	42
5	Public Health	1	1	16

L O Frøholm

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway G Bjune, E. Arne Høiby, Jon Ketil Grønnesby, The Lancet VaccinationMucosal VaccinationVaccine DevelopmentPathogenesisImmunology	1991	693
Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Dominique A. Caugant, L O Frøholm, K Bøvre, Proceedings of the National Academy of Sciences Pathogen DetectionInfectious DiseaseEt-5 ComplexIntercontinental SpreadPathogen Transmission	1986	313
Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population Dominique A. Caugant, E. Arne Høiby, P. K. Magnus, Journal of Clinical Microbiology Infectious Disease ModellingAntibioticsPathogen TransmissionHealthcare-associated InfectionNorwegian Population	1994	312
Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern Dominique A. Caugant, L F Mocca, Carl E. Frasch, Journal of Bacteriology BiologyMolecular EcologyGenetic StructurePathogenesisOuter Membrane Protein	1987	251
Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease. J. HOLST Fredriksen, Einar Rosenqvist, Elisabeth Wedege, PubMed VaccinationMucosal VaccinationOuter Membrane VesiclesReverse VaccinologyVaccine Development	1991	242
Multilocus Genotypes Determined by Enzyme Electrophoresis of Neisseria meningitidis Isolated from Patients with Systemic Disease and from Healthy Carriers Dominique A. Caugant, Peter Gaustad, Klaus Bryn, Microbiology Parasitic DiseasePathogen DetectionPathologyEnzyme ElectrophoresisSystemic Isolates	1986	140
Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers Dominique A. Caugant, Bjørn‐Erik Kristiansen, L O Frøholm, Infection and Immunity Healthy IndividualsMolecular EpidemiologyPathogen DetectionPathologyGenetic Diversity	1988	129
MENINGOCOCCAL SEROTYPES AND SEROGROUP B DISEASE IN NORTH-WEST EUROPE Jan Poolman, Kristín Jónsdóttir, DennisM. Jones, The Lancet Clinical InfectionInfection ControlBacterial MeningitisMedicineClinical Microbiology	1986	121
Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting Elisabeth Wedege, L O Frøholm Infection and Immunity VaccinationHuman Antibody ResponseOuter Membrane VesiclesMucosal VaccinationReverse Vaccinology	1986	108
Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey. E. Arne Høiby, Einar Rosenqvist, L O Frøholm, PubMed VaccinationVaccine DevelopmentVaccine ResearchVaccine TargetHuman Volunteers	1991	88

Page 1